Literature DB >> 6603982

Constitutive secretion of interleukin 1 by human monocytes.

A J Treves, V Barak, T Tal, Z Fuks.   

Abstract

The constitutive and lipopolysaccharide (LPS)-induced secretion of interleukin 1 (IL 1) by cultured human monocytes and macrophages has been studied. Both freshly obtained monocytes and their culture-derived macrophages were induced by LPS to secrete similar amounts of IL 1. Such induction, however, was accompanied by the secretion of dialyzed inhibitory activity. Constitutive secretion of IL 1 was detected in concentrated supernatants of monocyte cultures. The factor obtained constitutively did not manifest significant inhibitory activity. A method is described for the recovery of IL 1-containing supernatants in serum- and other stimulant-free medium. The biological activities of the constitutively secreted IL 1 were similar to the LPS-induced activities. The constitutive secretion of IL 1 was not equally distributed in the entire monocyte population. We found that a small fraction of loosely adherent monocytes secreted higher amounts of IL 1 than the strongly adherent monocytes. However, the property of higher secretion of IL 1 was not stable and disappeared following monocyte cultivation. Thus, constitutive activity of IL 1 could be recovered either by concentrating the culture supernatants or by enriching a subset of monocytes with higher IL 1 activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603982     DOI: 10.1002/eji.1830130808

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-alpha) response in patients on long term cuprophane haemodialysis.

Authors:  A Y Annenkov; A G Strokov; F S Baranova
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity.

Authors:  R C Newton
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

3.  Candida albicans polysaccharide extract (MPPS) and PPD stimulate the production of interleukin-1 and lymphocyte proliferation.

Authors:  G Lombardi; E Piccolella; D Vismara; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

4.  Role of monocytes in the inhibitory effect of calcitriol on PHA-stimulated lymphocytes.

Authors:  M T Zarrabeitia; J A Riancho; V Rodriguez-Valverde; M C Farinas; J Gonzalez-Macias
Journal:  Blut       Date:  1987-06

5.  Interleukin-2 and interferon-gamma recruit different subsets of human peripheral blood monocytes to secrete interleukin-1 beta and tumour necrosis factor-alpha.

Authors:  F Herrmann; G Gebauer; A Lindemann; M Brach; R Mertelsmann
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

6.  Examination of chemotactic properties of bovine mammary macrophages.

Authors:  I Politis; X Zhao; B W McBride; J H Burton
Journal:  Can J Vet Res       Date:  1991-10       Impact factor: 1.310

7.  Production of an early release, M(r) 36,000 monokine by stimulated rat macrophages.

Authors:  N M Hedberg; N Hunter; C Soussou; A E Knop
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

8.  Interleukin 1 in Crohn's disease.

Authors:  J Satsangi; R A Wolstencroft; J Cason; C C Ainley; D C Dumonde; R P Thompson
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

9.  Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro.

Authors:  K Selmaj; Z Nowak; H Tchórzewski
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.